1. Kuang JL, Wang JY, Li YT, Li MC, Zhao ML, Ge K, Zheng D, Cheung K, Liao BY, Wang SL, Chen TL, Zhang YN, Wang CR, Ji G, Chen P, Zhou HW, Xie C, Zhao AH, Jia WP, Zheng XJ, Jia W. Hyodeoxycholic acid alleviates nonalcoholic fatty liver disease through modulating the gut-liver axis. Cell Metab. 2023 Oct 3;35(10):1752-1766.
2. Zheng XJ, Chen TL, Jiang RQ, et al., Jia WP, Jiang CT, Jia W. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021 Apr 6;33(4):791-803.
3. Zheng XJ, Chen TL, Zhao AH, Ning ZC, et al, Lu AP, Jia WP, Jia W. Hyocholic acid species as novel biomarkers for metabolic disorder. Nat Commun. 2021 Mar 11;12(1):1487.
4. Sang, C. et al. Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease. J Proteome Res 20, 2340-2351, (2021).
5. Xie, G. et al. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection. BMC Med 18, 144, (2020).
6. Wang J, et al. Peripheral serum metabolomic profiles inform central cognitive impairment. Sci Rep. Aug 20;10(1):14059. (2020).
7. Wei M, et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. May;55:102766. (2020).
8. Huang FJ, et al., Bian ZX, Li HK, Zhao AH, Jia W. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun. 2019 Nov 29;10(1):4971.
9. Mahmoudian Dehkordi, S. et al. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement 15, 76-92, (2019).
10. Nho, K, et al. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement 15, 232-244, (2019).
11. Chen WL, et al., Chen Z, Chen SJ, Jia W. Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of acute myeloid leukemia with therapeutic potential. Cancer Cell. 2016 Oct 10;30(5):779-791.
12. Zhao, L. et al. A panel of free fatty acid ratios to predict the development of metabolic abnormalities in healthy obese individuals. Sci Rep 6, 28418, (2016).
13. Zhou K#, Xie G#, Wen J, Wang J, Pan W, Zhou Y, Xiao Y, Wang Y, Jia W, Cai W*. Histamine is correlated with liver fibrosis in biliary atresia. Dig Liver Dis. 2016 Aug;48(8):921-6.
14. Chen WL, et al., Chen Z, Chen SJ, Jia W. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood. 2014 Sep 4;124(10):1645-1654.
15. Ni, Y. et al. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals. EBioMedicine 2, 1513-1522, (2015).
16. Zheng XJ, Zhao AH, Xie GX, et al, Nicholson JK, Jia W. Melamine-induced renal toxicity Is mediated by the gut microbiota. Sci Transl Med. 2013 Feb 13;5(172):172ra22.
17. Gu, Y. et al. Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects. J Proteome Res 12, 5801-5811, (2013).
18. Yang J, et al. Potential metabolite markers of schizophrenia. Mol Psychiatry. Jan;18(1):67-78. (2013).
19. Chen T, et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics. Jul;10(7) (2011).
20. Xie, G. et al. Profiling of serum bile acids in a healthy Chinese population using UPLC-MS/MS. J Proteome Res 14, 850-859, (2015).